Schéma posologique : individualisation

Pharmacokinetic variability refers to differences in how the body processes drugs through absorption, distribution, metabolism, and excretion. Pharmacodynamic variability describes how individuals respond differently to the same drug concentration due to variations in receptors, endogenous substances, or physiological differences. Both contribute to interpatient differences in drug response.

Individualized dosing tailors medication to each person's unique response to optimize therapeutic benefits while minimizing risks. Human responses to drugs vary widely due to genetics, age, body weight, and organ function. What is effective for one patient may be inadequate or excessive for another, making personalized dosing essential for safe and effective treatment.

Therapeutic index is the ratio between a drug's effective dose and its toxic dose. Drugs with a narrow therapeutic index require precise dosing because small changes in plasma drug concentrations can cause significant fluctuations, potentially leading to therapeutic failure or adverse effects. In contrast, GRAS and over-the-counter drugs typically require less stringent individualization.

Intersubject variability occurs due to differences in genetics, disease state, age, body weight, and organ function among patients. These biological factors influence how a drug is absorbed, distributed, metabolized, and excreted, resulting in distinct pharmacological responses to the same drug dose. Understanding these differences is critical for determining appropriate dose strengths.

Intrasubject variability occurs when the same individual exhibits differences in plasma drug levels upon receiving the same medication on different occasions. In contrast, intersubject variability describes differences in drug responses between different patients. Both types of variability must be considered when establishing individualized dosage regimens.

Drugs with a narrow therapeutic index, such as warfarin and digoxin, require meticulous individualization. Small dosage changes can lead to significant fluctuations in plasma drug concentrations, potentially causing therapeutic failure or adverse reactions. These drugs demand precise dosing to maintain efficacy while avoiding toxicity.

Key factors include dose strengths, the degree of intersubject variability, and the therapeutic index. Determination of multiple dosing parameters loading and maintenance doses helps establish appropriate regimens. These elements work together to ensure that each patient receives a dose tailored to their unique pharmacokinetic and pharmacodynamic profile.